Connect with us

Hi, what are you looking for?

NEWSMAKERS

WHO spends more on travel than AIDS, hepatitis, malaria and TB combined, claims AP in exclusive report

The World Health Organization spends more money on travel costs than on fighting of AIDS, hepatitis, malaria and tuberculosis combined, according to a report from AP that noted that the UN health agency spends around $200 million a year on travel costs, while – last year – it only spent around $71 million on AIDS and hepatitis, $61 million on malaria, and $59 million on tuberculosis.

More resources spent on whim than necessity?

The World Health Organization (WHO) spends more money on travel costs than on fighting of AIDS, hepatitis, malaria and tuberculosis combined. This is according to a new and exclusive report from AP, which stated that the UN health agency spends around $200 million a year on travel costs; while – last year – it only spent around $71 million on AIDS and hepatitis, $61 million on malaria, and $59 million on tuberculosis. Since 2013, WHO has paid approximately $803 million for travel.

Some health programs do receive more substantial funding – e.g. WHO allocates $450 million to polio every year.

WHO is, nonetheless, asking for more money to fight disease, and UN member countries pay for the agency’s $2 billion annual budget.

According to the same AP report, WHO defended itself by noting that it already reduced travel costs by 14% last year.

Advertisement
Advertisement

Like Us On Facebook

YOU MAY ALSO LIKE

POZ

Aging markedly increases renal stem-cell susceptibility to TFV-induced telomere–mitochondrial dysfunction, oxidative stress, senescence, apoptosis, and functional injury, while highlighting the 3D silk matrix model...

POZ

The US Food and Drug Administration gave its seal of approval to a generic version of injectable lenacapavir, the drug that can protect from...

POZ

Tuberculosis (TB) is responsible for about a quarter of all AIDS deaths. In 2024, it was also the leading cause of death among people...

POZ

A new approach replaces rilpivirine with lenacapavir, a long-acting drug that attacks HIV in a different way.

Advertisement